Literature DB >> 29788220

Obstructive Sleep Apnea Syndrome and Metabolic Diseases.

Min Li1, Xiaoying Li1, Yan Lu1.   

Abstract

With the rapid changes in lifestyle in modern society, including the high nutritional intake and reduced physical activity, the incidence of metabolic diseases has been increasing year by year. Obstructive sleep apnea syndrome (OSAS) is a sleep disorder, usually characterized by sudden pauses of breathing during sleep and an interrupted sleep rhythm. Although the pathological mechanism remains poorly understood, it has been strongly associated with metabolic diseases, including obesity, insulin resistance, type 2 diabetes mellitus (T2DM), and nonalcoholic fatty liver disease (NAFLD). In the present mini-review, we briefly summarize the connections between OSAS, obesity, T2DM, and NAFLD, which might help us to better understand the pathogenesis of human diseases.

Entities:  

Mesh:

Year:  2018        PMID: 29788220     DOI: 10.1210/en.2018-00248

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  22 in total

1.  Validation of a portable monitoring device for the diagnosis of obstructive sleep apnea: electrocardiogram-based cardiopulmonary coupling.

Authors:  Mi Lu; Fang Fang; John E Sanderson; Chenyao Ma; Qianqian Wang; Xiaojun Zhan; Fei Xie; Lei Xiao; Hu Liu; Hongyan Liu; Yongxiang Wei
Journal:  Sleep Breath       Date:  2019-08-13       Impact factor: 2.816

Review 2.  Impact of sleep apnea and treatments on cardiovascular disease.

Authors:  Andre Faria; Arthur Macedo; Carolina Castro; Elke Valle; Raquel Lacerda; Najib Ayas; Ismail Laher
Journal:  Sleep Sci       Date:  2022 Apr-Jun

3.  Brazilian Thoracic Association Consensus on Sleep-disordered Breathing.

Authors:  Ricardo Luiz de Menezes Duarte; Sonia Maria Guimarães Pereira Togeiro; Luciana de Oliveira Palombini; Fabíola Paula Galhardo Rizzatti; Simone Chaves Fagondes; Flavio José Magalhães-da-Silveira; Marília Montenegro Cabral; Pedro Rodrigues Genta; Geraldo Lorenzi-Filho; Danielle Cristina Silva Clímaco; Luciano Ferreira Drager; Vitor Martins Codeço; Carlos Alberto de Assis Viegas; Marcelo Fouad Rabahi
Journal:  J Bras Pneumol       Date:  2022-07-08       Impact factor: 2.800

4.  Cardiovascular and metabolic effects of a mandibular advancement device and continuous positive airway pressure in moderate obstructive sleep apnea: a randomized controlled trial.

Authors:  Julia A M Uniken Venema; Grietje E Knol-de Vries; Harry van Goor; Johanna Westra; Aarnoud Hoekema; Peter J Wijkstra
Journal:  J Clin Sleep Med       Date:  2022-06-01       Impact factor: 4.324

5.  Association between non-alcoholic fatty liver disease and obstructive sleep apnea.

Authors:  Ilaria Umbro; Valerio Fabiani; Mario Fabiani; Francesco Angelico; Maria Del Ben
Journal:  World J Gastroenterol       Date:  2020-05-28       Impact factor: 5.742

6.  Alterations in Serum Adropin, Adiponectin, and Proinflammatory Cytokine Levels in OSAS.

Authors:  Hakan Celikhisar; Gulay Dasdemir Ilkhan
Journal:  Can Respir J       Date:  2020-05-04       Impact factor: 2.409

Review 7.  Recent Advances in Studies on the Role of Neuroendocrine Disorders in Obstructive Sleep Apnea-Hypopnea Syndrome-Related Atherosclerosis.

Authors:  Wanda Wang; Yanli Zheng; Meimei Li; Shu Lin; Huili Lin
Journal:  Nat Sci Sleep       Date:  2021-07-27

8.  Proper Management of People with Obesity during the COVID-19 Pandemic.

Authors:  Soo Lim; Soo Myoung Shin; Ga Eun Nam; Chang Hee Jung; Bo Kyung Koo
Journal:  J Obes Metab Syndr       Date:  2020-06-30

9.  Editorial: Diabetes and Obesity Effects on Lung Function.

Authors:  Xiao-Feng Chen; Liang-Jun Yan; Albert Lecube; Xiaoqiang Tang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-16       Impact factor: 5.555

10.  Socioeconomic inequalities in pediatric obstructive sleep apnea.

Authors:  Ji Woon Park; Mona M Hamoda; Fernanda R Almeida; Zitong Wang; David Wensley; Bassam Alalola; Mohammed Alsaloum; Yasue Tanaka; Nelly T Huynh; Annalijn I Conklin
Journal:  J Clin Sleep Med       Date:  2022-02-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.